Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEYOND Follow-Up Study of Betaseron in Relapsing MS
NCT00459667Phase 3Completed
- Sponsor
- Bayer
- Start
- May 2007
- Primary completion
- Mar 2008
- Modality
- Interferons
- Countries
- 26
01
Overview
Phase 3, double-blind trial of interferon beta in multiple sclerosis (MS) (3 arms), sponsored by Bayer. Primary endpoints: Flu-like-syndrome at 309 days, Injection-site Reactions at 309 days and 2 more. Started May 2007; status: completed.
02
Drugs
interferon beta
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00459667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00459667.